company background image
NXGN logo

Nextgen Biomed TASE:NXGN Stock Report

Last Price

₪0.65

Market Cap

₪6.3m

7D

-5.1%

1Y

-65.6%

Updated

12 Nov, 2024

Data

Company Financials

Nextgen Biomed Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Nextgen Biomed
Historical stock prices
Current Share Price₪0.65
52 Week High₪1.90
52 Week Low₪0.62
Beta0.85
11 Month Change-3.98%
3 Month Change-29.21%
1 Year Change-65.61%
33 Year Change-95.98%
5 Year Change-61.19%
Change since IPO-98.64%

Recent News & Updates

Recent updates

We Think Nextgen Biomed (TLV:NXGN) Can Afford To Drive Business Growth

Aug 22
We Think Nextgen Biomed (TLV:NXGN) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About Nextgen Biomed's (TLV:NXGN) Cash Burn Situation

May 02
Here's Why We're Not Too Worried About Nextgen Biomed's (TLV:NXGN) Cash Burn Situation

We're Hopeful That Nextgen Biomed (TLV:NXGN) Will Use Its Cash Wisely

Jan 13
We're Hopeful That Nextgen Biomed (TLV:NXGN) Will Use Its Cash Wisely

Shareholder Returns

NXGNIL PharmaceuticalsIL Market
7D-5.1%-11.4%3.2%
1Y-65.6%-5.5%28.5%

Return vs Industry: NXGN underperformed the IL Pharmaceuticals industry which returned -4.3% over the past year.

Return vs Market: NXGN underperformed the IL Market which returned 30% over the past year.

Price Volatility

Is NXGN's price volatile compared to industry and market?
NXGN volatility
NXGN Average Weekly Movement8.3%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement4.0%
10% most volatile stocks in IL Market7.2%
10% least volatile stocks in IL Market2.7%

Stable Share Price: NXGN's share price has been volatile over the past 3 months compared to the IL market.

Volatility Over Time: NXGN's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of IL stocks.

About the Company

FoundedEmployeesCEOWebsite
19905Harel Hershtikwww.nextgen-biomed.com

Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group Com Ltd.

Nextgen Biomed Ltd Fundamentals Summary

How do Nextgen Biomed's earnings and revenue compare to its market cap?
NXGN fundamental statistics
Market cap₪6.30m
Earnings (TTM)-₪13.81m
Revenue (TTM)n/a

0.0x

P/S Ratio

-0.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NXGN income statement (TTM)
Revenue₪0
Cost of Revenue₪0
Gross Profit₪0
Other Expenses₪13.81m
Earnings-₪13.81m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.43
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did NXGN perform over the long term?

See historical performance and comparison